Want to see IT:FDA full AI Analyst Report?

Fidia Spa (FDA) Ratios

6 Followers

Fidia Spa Ratios

IT:FDA's free cash flow for Q4 2025 was €0.57. For the 2025 fiscal year, IT:FDA's free cash flow was decreased by € and operating cash flow was €-0.03. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.30	1.30	0.82	0.86	4.83
Quick Ratio	0.75	0.75	0.34	0.44	2.48
Cash Ratio	0.18	0.18	0.07	0.12	1.13
Solvency Ratio	0.09	0.12	-0.32	>-0.01	1.69
Operating Cash Flow Ratio	-0.25	-0.27	-0.18	-0.19	0.18
Short-Term Operating Cash Flow Coverage	-2.66	-2.94	-4.28	-0.98	0.42
Net Current Asset Value	€ -1.03M	€ -1.03M	€ -5.82M	€ -6.80M	€ 16.25M
Leverage Ratios
Debt-to-Assets Ratio	0.20	0.20	0.04	0.36	0.26
Debt-to-Equity Ratio	0.65	0.65	0.34	3.56	1.39
Debt-to-Capital Ratio	0.39	0.39	0.26	0.78	0.58
Long-Term Debt-to-Capital Ratio	0.33	0.33	0.10	0.28	0.00
Financial Leverage Ratio	3.27	3.27	9.61	10.00	5.39
Debt Service Coverage Ratio	-0.87	-0.45	-5.65	0.08	3.45
Interest Coverage Ratio	0.00	-2.52	-16.55	-2.70	-13.46
Debt to Market Cap	0.54	0.29	<0.01	0.01	<0.01
Interest Debt Per Share	<0.01	0.04	0.04	1.74	1.25
Net Debt to EBITDA	-3.72	-4.42	0.09	12.40	0.44
Profitability Margins
Gross Profit Margin	63.30%	24.18%	74.17%	66.88%	5.94%
EBIT Margin	-4.34%	-5.58%	-50.25%	-2.15%	24.17%
EBITDA Margin	-2.41%	-2.08%	-43.80%	2.33%	31.31%
Operating Profit Margin	-2.23%	-5.58%	-37.58%	-5.76%	-21.81%
Pretax Profit Margin	3.94%	4.04%	-52.52%	-4.28%	22.77%
Net Profit Margin	3.32%	3.40%	-53.17%	-4.57%	24.49%
Continuous Operations Profit Margin	3.22%	3.30%	-54.31%	-5.15%	23.61%
Net Income Per EBT	84.27%	84.27%	101.25%	106.69%	107.57%
EBT Per EBIT	-176.39%	-72.40%	139.75%	74.33%	-104.37%
Return on Assets (ROA)	3.94%	3.94%	-32.85%	-4.06%	18.57%
Return on Equity (ROE)	17.04%	12.88%	-315.72%	-40.62%	100.02%
Return on Capital Employed (ROCE)	-5.34%	-13.01%	-148.33%	-25.27%	-19.10%
Return on Invested Capital (ROIC)	-3.60%	-9.71%	-120.70%	-14.35%	-17.89%
Return on Tangible Assets	4.07%	4.07%	-33.41%	-4.18%	19.17%
Earnings Yield	19.33%	5.65%	-5.91%	-0.21%	0.57%
Efficiency Ratios
Receivables Turnover	4.51	4.75	3.94	5.21	3.45
Payables Turnover	2.25	4.53	0.80	1.58	4.16
Inventory Turnover	1.58	3.19	0.40	0.89	2.26
Fixed Asset Turnover	4.18	4.08	2.30	3.47	2.61
Asset Turnover	1.19	1.16	0.62	0.89	0.76
Working Capital Turnover Ratio	7.82	-176.47	-4.34	4.47	4.31
Cash Conversion Cycle	149.40	110.83	556.22	250.10	179.60
Days of Sales Outstanding	80.98	76.86	92.72	70.05	105.86
Days of Inventory Outstanding	230.77	114.56	919.41	411.61	161.38
Days of Payables Outstanding	162.35	80.59	455.91	231.56	87.64
Operating Cycle	311.75	191.42	1.01K	481.66	267.24
Cash Flow Ratios
Operating Cash Flow Per Share	>-0.01	-0.02	-0.13	-0.70	0.11
Free Cash Flow Per Share	>-0.01	-0.03	-0.13	-0.77	0.07
CapEx Per Share	<0.01	<0.01	<0.01	0.07	0.04
Free Cash Flow to Operating Cash Flow	1.13	1.12	1.02	1.10	0.62
Dividend Paid and CapEx Coverage Ratio	-7.73	-8.54	-40.21	-10.18	2.66
Capital Expenditure Coverage Ratio	-7.73	-8.54	-40.21	-10.18	2.66
Operating Cash Flow Coverage Ratio	-0.63	-0.69	-4.28	-0.42	0.10
Operating Cash Flow to Sales Ratio	-0.10	-0.12	-0.25	-0.17	0.03
Free Cash Flow Yield	-38.09%	-22.07%	-2.83%	-0.86%	0.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.27	17.75	-17.11	-472.04	174.84
Price-to-Sales (P/S) Ratio	0.31	0.60	9.00	21.57	42.82
Price-to-Book (P/B) Ratio	0.67	2.28	53.46	191.72	174.87
Price-to-Free Cash Flow (P/FCF) Ratio	-2.63	-4.53	-35.37	-116.14	2.11K
Price-to-Operating Cash Flow Ratio	-1.64	-5.06	-36.25	-127.55	1.32K
Price-to-Earnings Growth (PEG) Ratio	>-0.01	-0.17	-0.41	3.87	-0.77
Price-to-Fair Value	0.67	2.28	53.46	191.72	174.87
Enterprise Value Multiple	-16.65	-33.36	-20.47	937.38	137.18
Enterprise Value	12.55M	21.18M	156.78M	625.23M	1.05B
EV to EBITDA	-16.65	-33.36	-20.47	937.38	137.18
EV to Sales	0.40	0.69	8.97	21.86	42.96
EV to Free Cash Flow	-3.38	-5.22	-35.22	-117.70	2.11K
EV to Operating Cash Flow	-3.82	-5.83	-36.10	-129.26	1.32K
Tangible Book Value Per Share	0.01	0.05	0.07	0.36	3.84
Shareholders’ Equity Per Share	0.01	0.05	0.09	0.46	0.86
Tax and Other Ratios
Effective Tax Rate	0.26	0.18	-0.03	-0.20	-0.04
Revenue Per Share	0.05	0.20	0.51	4.13	3.51
Net Income Per Share	<0.01	<0.01	-0.27	-0.19	0.86
Tax Burden	0.84	0.84	1.01	1.07	1.08
Interest Burden	-0.91	-0.72	1.05	1.99	0.94
Research & Development to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
SG&A to Revenue	0.31	0.28	0.16	0.07	0.05
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	-3.16	-3.49	0.46	3.70	0.13

Currency in EUR